- Home
- SELF vs VRCA Comparison
SELF vs VRCA Comparison
Compare SELF & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SELF | VRCA |
|---|---|---|
| Founded | 1983 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 32.7M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SELF | VRCA |
|---|---|---|
| Price | $5.08 | $8.30 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.3K | ★ 359.1K |
| Earning Date | 11-07-2025 | 11-14-2025 |
| Dividend Yield | ★ 5.73% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | $12,733,279.00 | ★ $30,829,000.00 |
| Revenue This Year | $1.59 | $332.45 |
| Revenue Next Year | $1.62 | $12.85 |
| P/E Ratio | $31.57 | ★ N/A |
| Revenue Growth | 3.36 | ★ 234.73 |
| 52 Week Low | $4.73 | $3.28 |
| 52 Week High | $5.89 | $12.50 |
Technical Indicators
Market Signals| Indicator | SELF | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 49.74 | 70.38 |
| Support Level | $5.03 | $6.26 |
| Resistance Level | $5.19 | $9.82 |
| Average True Range (ATR) | 0.11 | 0.90 |
| MACD | -0.00 | 0.42 |
| Stochastic Oscillator | 36.36 | 77.65 |
Price Performance
Historical ComparisonAbout SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.